[1] PELEG A Y, SEIFERT H, PATERSON D L. Acinetobacter baumannii: emergence of a successful pathogen [J]. Clinical Microbiology Reviews, 2008, 21(3): 538 − 582. doi:  10.1128/CMR.00058-07
[2] ALSAN M, KLOMP AS M. Acinetobacter baumannii: An emerging and important pathogen [J]. Journal of Clinical Outcomes Management, 2010, 17(8): 27 − 35.
[3] 李欢, 郑锐. 鲍曼不动杆菌血流感染的研究进展[J]. 中国微生态学杂志, 2020, 32(4): 487 − 491.
[4] A JAWAD, H SEIFERT, A M SNELLING, et al. Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates [J]. Journal of Clinical Microbiology, 1998, 36(7): 1938 − 1941. doi:  10.1128/JCM.36.7.1938-1941.1998
[5] JENNIFER A GADDY, LUIS A ACTIS. Regulation of Acinetobacter baumonnii biofilm formation [J]. Future Microbiology, 2009, 4(3): 273 − 278. doi:  10.2217/fmb.09.5
[6] NWADIKE V, OJIDE C, KALU E. Multidrug resistant Acinetobacter infection and their antimicrobial susceptibility pattern in a Nigerian tertiary hospital ICU. [J]. Afr J Infect Dis, 2014, 8(1): 14 − 18.
[7] HASSEN A B, MARQUET D M, GUEDIRA S, et al. Epidemiological analysis of Acinetobacter baumannii strains isolated from a surgical intensive care unit [J]. Annales De Biologie Clinique, 1995, 53(9): 491.
[8] VILLAR M, CANO M E, GATO E, et al. Epidemiologic and clinical impact of Acinetobacter baumannii colonization and infection [J]. Medicine, 2014, 93(5): 202 − 210. doi:  10.1097/MD.0000000000000036
[9] 王孝武, 王旭荣, 杨志强, 等. 奶牛子宫内膜炎研究进展[J]. 动物医学进展, 2014, 35(7): 98 − 102.
[10] 葛东红, 周明旭, 朱纯, 等. 江苏某牛场生牛乳中肺炎克雷伯菌和鲍曼不动杆菌的分离鉴定, 耐药性和毒力分析[J]. 中国兽医学报, 2019, 39(6): 98 − 102+120.
[11] 钟世勋, 李兵, 王迪, 等. 山羊鲍曼不动杆菌分离鉴定和病原性研究[J]. 中国预防兽医学报, 2014, 36(8): 632 − 635.
[12] 崔颖鹏, 黄朱亮. 细菌16S核糖体RNA基因检测杰氏棒状杆菌一株[J]. 中华诊断学电子杂志, 2015, 3(4): 296 − 299.
[13] 布坎南, 吉本斯. 伯杰细菌鉴定手册. 8版[M]. 北京: 科学出版社, 1984.
[14] SINGH S, BHATT D, SONI I. Evaluation of LD50 of fenvalerate in male wistar rats by miller and tainter method [J]. Journal of Ecophysiology and Occupational Health, 2020, 20(3/4): 159 − 164.
[15] AL-ALI A, ALKHAWAJAH A A, RANDHAWA M A, et al. Oral and intraperitoneal LD50 of thymoquinone, an active principle of Nigella sativa, in mice and rats [J]. J Ayub Med Coll Abbottabad, 2008, 20(2): 25 − 27.
[16] 谭瑶, 赵清, 舒为群, 等. K-B纸片扩散法药敏试验[J]. 检验医学与临床, 2010, 7(20): 2290 − 2290.
[17] 黄至澄, 闫李侠, 王伟平, 等. 鲍曼不动杆菌对小鼠致死剂量的研究[J]. 江西医药, 2011, 46(11): 986 − 987.
[18] 韦永孜, 陈茂伟, 张春兰, 等. 某医院2015—2019年间多重耐药鲍曼不动杆菌的分布特征及其耐药性分析[J]. 抗感染药学, 2020, 17(10): 1424 − 1426.
[19] 刘勃兴, 赵安奇, 吴同垒, 等. 一株鸡源鲍曼不动杆菌的分离鉴定[J]. 现代畜牧兽医, 2020(7): 1 − 4.
[20] 周珊, 徐修礼, 樊新, 等. 神经外科鲍曼不动杆菌, 铜绿假单胞菌及金黄色葡萄球菌的分布及耐药性分析[J]. 临床合理用药杂志, 2013, 6(10): 9 − 11.
[21] F PEREZ, HUJER A M, HUJER K M, et al. Global challenge of multidrug-resistant Acinetobacter baumannii [J]. Antimicrobial Agents & Chemotherapy, 2007, 51(10): 3471.
[22] HIROTO, USHIZAWA, YUICHIRO, et al. An Epidemiological investigation of a nosocomial outbreak of multidrug-resistant Acinetobacter baumannii in a critical care center in Japan, 2011—2012 [J]. Japanese Journal of Infectious Diseases, 2016, 69(2): 143 − 148. doi:  10.7883/yoken.JJID.2015.049
[23] WAREHAM D W, BEAN D C. In-vitro activity of polymyxin B in combination with imipenem, rifampicin and azithromycin versus multidrug resistant strains of Acinetobacter baumannii producing OXA-23 carbapenemases [J]. Ann Clin Microbiol Antimicrob, 2006, 5(1): 1 − 5. doi:  10.1186/1476-0711-5-1